An autosomal dominant disorder in which Fibrinogen is quantitatively normal but qualitatively abnormal due to mutations in the fibrinogen gene. Patients with this abnormality can either bleed or thrombose. A key laboratory finding is prolongation of the Thrombin Time test.
